Regulation makers, along with other stakeholders in Culture, may very well be skeptical about re-dispensing returned medicines with out proper validation [sixteen]. This portion describes how newest technologies collected through the literature evaluation can enable the reuse of returned medicines based on the two teams of stakeholder specification